港股異動丨方舟健客放量飆升35%
國內最大在線慢病管理平臺方舟健客(6086.HK)盤中逆勢拉昇,一度漲35.35%報5.59港元,截至目前成交額放大至2億港元。公司3月份公佈的財報顯示,2024年收入27.07億元,同比增長11.22%;經調整利潤淨額1711.9萬元,較2023年大幅增長139%,受益於技術不斷加強及運營效率提高。今年春節期間,DeepSeek橫空出世,成爲中國AI發展史上的里程碑。作爲在AI醫療賽道領跑的方舟健客,第一時間通過自研AI應用平臺接入DeepSeek開源大模型,並完成私有化部署。方舟健客作爲互聯網醫療行業的頭部企業,通過AI驅動實現了H2H(Hospital to Home)智慧醫療業務生態體系的全面升級,並完成一系列“AI+醫療”新場景落地應用。華泰證券認爲,AI正在構建醫療新範式,AI醫療2025年大有可爲,強調2025年“AI+醫療”將迎來跨越式發展,應重視相關投資機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.